Dublin, June 02, 2023 (GLOBE NEWSWIRE) -- The "Custom Antibody Market Size, Share & Trends Analysis Report By Type (Monoclonal), By Service (Antibody Development), By Source (Mice), By Application, By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global custom antibody market size is expected to reach USD 301.7 million by 2030, expanding at a CAGR of 9.7% from 2023 to 2030.
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Abcam plc
- Bio-Rad Laboratories, Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies, LLC.
- Abmart
- Labcorp Drug Development
- LifeSpan BioSciences, Inc
- GenScript
The market is expected to witness substantial growth during the forecast period. This growth is attributed to the increasing fundraising by biotech startups for developing innovative products. Additionally, rising awareness of personalized diagnostic and therapeutic treatments in emerging markets is also a contributing factor to the growth of the custom antibody market.
Increasing investment by the players to expand their services in the development and production of antibodies is likely to support the growth of the market. For instance, Absolute Antibody Ltd. is into the services of custom antibody sequencing, expression, and engineering.
In August 2022, the company announced the expansion of its manufacturing facility by increasing the lab space and investing in automated technology such as next-generation sequencing, purification, and expression. The expansion is expected to improve the production workflow for recombinant antibodies.
Similarly, companies are also improving the application of custom antibodies. According to an article published in January 2023, MilliporeSigma is planning to develop new antibodies through its Cell Marque Tissue Diagnostics technology.
The rabbit polyclonal antibody is customized to detect a type of glioma, ATRX. Gliomas account for 30% of tumors in the central nervous system. Through this antibody, the company is anticipated to expand its portfolio in neuropathology.
Monetary support to academic and research institutions through grants from regulatory bodies and discount offers on services by companies are anticipated to enhance custom antibody discovery and research during the forecast period.
For instance, Absolute antibody offers 10% off on custom services, while a similar discount is also offered by AltaBioscience for a limited time period. The discounts are expected to reduce the overall cost of production for researchers.
However, the high cost of producing custom monoclonal antibodies is expected to restrain the growth of the custom antibody market. The average estimated cost is around USD 6,000 to 15,000. The cost acts as a market entry barrier for various startups and emerging players. However, the cost can be reduced by developing reliable production reagents and techniques to avoid the upfront cost.
Custom Antibody Market Report Highlights
- By type, the monoclonal antibody segment is considered to be a relatively more mature and dominant segment than polyclonal in 2022. The increasing R&D investment by companies is expected to support the growth of the custom antibody market
- By service, the antibody development segment captured the majority of the custom antibody market share in 2022. The number and type of players in this service segment are greater than antibody production and fragmentation, which is contributing to the growth
- By source, the mice segment is estimated to be the fastest-growing during the forecast period. This is because mice are widely available lab animals and can be easily used for custom antibody production
- By application, infectious disease is considered the key segment with the largest market share in 2022, and this trend is likely to be maintained over the forecast period. This growth can be attributed to the emerging infectious diseases in developing countries
- By end-users, the academic and research institutions segment is estimated to be the fastest-growing segment, with the largest market share in 2022. The growth is attributed to the increasing grants and financial assistance from governments and companies
- North America has established a strong regional position in the market with 44.91% of the overall market share in 2022. The increasing incidence rate of cancer and high R&D expenditure are encouraging companies to undertake product development in the region
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $147.6 Million |
| Forecasted Market Value (USD) by 2030 | $301.7 Million |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing demand for customized diagnostics and therapeutics
3.4.2. Ease of collaboration and partnerships among players
3.4.3. Increasing initiatives by the regulatory bodies
3.5. Market Restraint Analysis
3.5.1. High cost of production
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter's Five Forces Analysis
3.8. COVID-19 Impact Analysis
Chapter 4. Type Business Analysis
4.1. Custom Antibody Market: Type Movement Analysis
4.2. Monoclonal Antibodies
4.2.1. Monoclonal Antibodies Market, 2018 - 2030 (USD Million)
4.3. Polyclonal Antibodies
4.3.1. Polyclonal Antibodies Market, 2018 - 2030 (USD Million)
4.4. Recombinant Antibodies
4.4.1. Recombinant Antibodies Market, 2018 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Service Business Analysis
5.1. Custom Antibody Market: Service Movement Analysis
5.2. Antibody Development
5.2.1. Antibody Development Market, 2018 - 2030 (USD Million)
5.3. Antibody Production & Purification
5.3.1. Antibody Production & Purification Market, 2018 - 2030 (USD Million)
5.4. Antibody Fragmentation & Labelling
5.4.1. Antibody Fragmentation & Labelling Market, 2018 - 2030 (USD Million)
Chapter 6. Source Business Analysis
6.1. Custom Antibody Market: Source Movement Analysis
6.2. Mice
6.2.1. Mice Market, 2018 - 2030 (USD Million)
6.3. Rabbit
6.3.1. Rabbit Market, 2018 - 2030 (USD Million)
6.4. Others
6.4.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Application Business Analysis
7.1. Custom Antibody Market: Application Movement Analysis
7.2. Oncology
7.2.1. Oncology Market, 2018 - 2030 (USD Million)
7.3. Infectious Diseases
7.3.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
7.4. Neurology
7.4.1. Neurology Market, 2018 - 2030 (USD Million)
7.5. Stem cells
7.5.1. Stem cells Market, 2018 - 2030 (USD Million)
7.6. Immunology
7.6.1. Immunology Market, 2018 - 2030 (USD Million)
7.7. Cardiovascular Diseases
7.7.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. End-user Business Analysis
8.1. Custom Antibody Market: End-user Movement Analysis
8.2. Pharmaceutical & Biotechnology Companies
8.2.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
8.3. Academic & Research Institutes
8.3.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
8.4. CRO
8.4.1. CRO Market, 2018 - 2030 (USD Million)
8.5. Hospitals and Clinics
8.5.1. Hospitals and Clinics Market, 2018 - 2030 (USD Million)
Chapter 9. Regional Business Analysis
Chapter 10. Competitive Landscape
For more information about this report visit https://www.researchandmarkets.com/r/adalio
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
